FRI-490-The real world practice of systemic therapies in patients with advanced hepatocellular carcinoma in Japan: what has changed since lenvatinib approval?

Authors :: Masanori Inoue
Ryosaku Azemoto
Masanori Atsukawa
Yoshihiko Ooka
Sadahisa Ogasawara
Makoto Arai
Atsuyoshi Seki
Susumu Maruta
Shinichiro Okabe
Kazufumi Kobayashi
Yuki Haga
Shingo Nakamoto
Nobuyuki Sugiura
Masamichi Obu
Akinobu Tawada
Hitoshi Maruyama
Tatsuo Kanda
Naoya Kato
Eiichiro Suzuki
Tetsuhiro Chiba
Takahiro Maeda
Hideaki Mizumoto
Ei Itobayashi
Norio Itokawa
Shin Yasui
Source :: Journal of Hepatology. 70:e614-e615
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Oncology
medicine.medical_specialty
chemistry.chemical_compound
Hepatology
chemistry
business.industry
Internal medicine
Hepatocellular carcinoma
medicine
In patient
business
medicine.disease
Lenvatinib

Full Text Access

Tools